Congressional Hearings Focus on FDA’s Handling of Avandia
Rep. Henry Waxman (D-Calif.), chairman of the Committee on Oversight and Government Reform, accused the FDA of being to lax in monitoring the safety of Avandia. He said the FDA never completed a required post-market study of the drug, constituting “a major failure of our system.”
“It’s about time someone recognizes the flaws in our drug approval and monitoring processes,” says W. Mark Lanier of The Lanier Law Firm in Houston. “It is far too easy for dangerous drugs to stay on the market simply because they are profitable.”
The hearings were prompted by a recent New England Journal of Medicine article suggesting that Avandia significantly increases the risk of heart attacks and cardiovascular death. The article analyzed several clinical trials comparing patients taking Avandia with those not using the drug. The results indicated Avandia increased patients’ chances of heart attack by 43 percent and cardiac-related death by 64 percent.
In response to the article, the FDA issued a Safety Alert advising patients to talk with their doctor about Avandia’s risks. Nearly seven million people worldwide have taken Avandia.
The Lanier Law Firm is currently investigating claims against Avandia and its manufacturer, GlaxoSmithKline. The firm’s Pharmaceutical Liability Practice Group has decades of experience representing clients who have been injured by dangerous drugs.
With offices in Houston and New York, The Lanier Law Firm is committed to addressing client concerns with effective and innovative solutions. The firm is composed of outstanding trial attorneys with decades of experience handling cases involving pharmaceutical liability, asbestos exposure, business fraud, serious personal injuries, product liability, and toxic exposure.
The Lanier Law Firm
Houston Law Office
6810 FM 1960 West
Houston, Texas 77069
(713) 659-2204 – Fax
New York Law Office
Lanier Law Firm, PLLC
126 East 56th Street, 6th Floor
New York, NY 10022
(212) 421-2878 – Fax
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Congressional Hearings Focus on FDA’s Handling of Avandia here
News-ID: 22062 • Views: 1331
More Releases from The Lanier Law Firm
The Lanier Law Firm Joins Lawsuit Against EA Sports over ‘NCAA Football’ Vid …
Mass tort lawyer of the year joins team representing former student-athlete HOUSTON – Noted courtroom attorney Mark Lanier of the The Lanier Law Firm has joined the trial team representing former Rutgers University quarterback Ryan Hart in a closely watched right-to-publicity lawsuit against video game publisher EA Sports. Mr. Hart is seeking compensation for the unapproved use of his likeness and physical description in a series of EA Sports’ popular “NCAA Football”
Former Houston Texans Punter Sues Over Injury Caused by Reliant Stadium Field
HOUSTON – A former punter for the National Football League’s Houston Texans has filed a state district court lawsuit against the owners and managers of Reliant Stadium based on claims that the stadium’s poor field conditions caused him to suffer a career-threatening leg injury. Brett Hartmann was the NFL’s leading rookie punter when the Texans played the Atlanta Falcons on Dec. 4, 2011. In the game’s closing moments, Mr. Hartmann was
East Texas Patent Infringement Lawsuits Target Google, Yahoo!, Others Over Cloud …
SHERMAN, Texas – The Lanier Law Firm is announcing a series of patent infringement lawsuits filed on behalf of Longview, Texas-based Titanide Ventures LLC against a group of companies accused of infringing patents covering cloud storage technology. The lawsuits are filed in the U.S. District Court for the Eastern District of Texas, Sherman Division, against Mountain View, Calif.-based Google Inc. (NASDAQ: GOOG), Sunnyvale, Calif.-based Yahoo! Inc. (NASDAQ: YHOO), Los Altos, Calif.-based
The Lanier Law Firm Leads National Conference on Asbestos Litigation
HOUSTON – Trial attorney Richard Meadow, who leads the New York office of The Lanier Law Firm, is serving as Co-Chair of an upcoming national conference on asbestos litigation. The law firm is one of the lead sponsors for “Trying an Asbestos Case – How to Get the ‘W’,” an informative program for the nation’s top asbestos attorneys taking place on Jan 25, 2011, at the Hub Cira Centre in Philadelphia.
More Releases for Avandia
BRIC Diabetes Drugs Market Will Generate New Growth Opportunities by 2021
Diabetes is a chronic disease characterized by high blood sugar level. It is caused by the improper functioning of the pancreas which secretes insulin. Diabetes is also known as diabetes mellitus. High blood sugar leads to increased thirst and hunger, and frequent urination. Lack of treatment for diabetes causes several complications such as diabetes ketoacidosis, heart disease, stroke, and kidney failures. Insulin infusion therapy is used to treat diabetes. Get access
Email Reveals DePuy Knew of ASR Hip Problems Before Recall Was Issued
Nadrich & Cohen, LLP reports on a recent email which suggests that Johnson & Johnson was aware of problems with its DePuy ASR hips for a year before the devices were ever recalled. Los Angeles, CA, February 28, 2012 – Nadrich & Cohen, LLP, a national law firm specializing in representing plaintiffs injured by medical devices, has previously reported on the developments in the ongoing controversy surrounding the now-recalled DePuy
GlaxoSmithKline Agrees to Settlement in 20,000 Avandia Lawsuits
Nadrich & Cohen, LLP reports that GlaxoSmithKline has agreed to settle approximately 20,000 Avandia side effects lawsuits. Los Angeles, CA, February 3, 2012 – UK drug-maker GlaxoSmithKline has agreed to settle 20,000 Avandia side effects lawsuits. According to a Bloomberg report, the company previously agreed to pay at least $700 million to settle more than 15,000 claims on behalf of patients who said that the drug caused heart attacks, strokes
Johnson & Johnson Reports Sales Up, Revenues Down Following DePuy Hip Recall
Nadrich & Cohen, LLP reports that Johnson & Johnson’s net earnings are down following the 2010 DePuy hip recall. Los Angeles, CA, January 25, 2012 – The Johnson & Johnson Company reported that sales were up in the fourth quarter but revenues were sharply down, due largely in part to costs associated with litigation settlements and the 2010 DePuy metal hip recall. The earnings announcement comes just a week after
Nadrich & Cohen LLP Clarifies Statements Regarding Actos Bladder Cancer Lawsuits
Los Angeles, CA, January 24, 2012 – National law firm Nadrich & Cohen LLP would like to clarify previous statements regarding the pending Actos bladder cancer litigation. Earlier press releases included incorrect information regarding the total number of Actos lawsuits filed against the drug’s manufacturer, Takeda Pharmaceuticals. Those releases, based on media reports, estimated the number of lawsuits filed in state and federal courts nationwide in connection with Actos numbered
FDA Warning Prompts DePuy Orthopaedics to Halt Sale of Custom Joint Replacements
Nadrich & Cohen, LLP reports that Johnson & Johnson’s DePuy Orthopaedics is halting the sale of certain custom joint replacements after receiving a warning from the U.S. Food and Drug Administration. Los Angeles, CA, January 20, 2012 – Johnson & Johnson’s DePuy Orthopaedics says it will stop selling custom-fitted joint replacement devices after being warned by the U.S. Food and Drug Administration that the products were not in compliance with